MedX Health Corp. MDXHF
0.03
0.00
0.00%
as of 24 Sep
- Market cap
- $103.2M
- P/E
- 0.0×
Follow MDXHF
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 63.45% | 68.26% | 54.70% | 53.97% |
+8 more TTM periods Free account |
|
| (867.29%) | (784.32%) | (487.89%) | (502.09%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
73.83% | 66.31% | 61.68% | 61.42% | |
Average Days of Receivables |
66.93 | 97.93 | 359.84 | 322.38 | |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow |
(3.91) | (3.77) | (3.59) | (3.54) | |
Capital Expenditures |
(0.99) | (1.10) | (1.29) | (1.24) | |
Piotroski F-Score |
2.00 | 3.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
62.40% | 46.48% | 53.30% | 61.52% | |
Accounts Receivable Turnover |
2.56 | 2.22 | 1.36 | 1.46 | |
Accounts Payable Turnover |
0.22 | 0.22 | 0.13 | 0.12 | |
Inventory Turnover |
2.17 | 1.85 | 0.85 | 0.76 | |
Average Days of Payables |
1,656.79 | 1,699.98 | 2,984.39 | 2,980.83 | |
Days of Inventory on Hand |
93.85 | 130.14 | 422.37 | 496.47 | |
Tax Rate |
0.00 | 0.00 | 0.14 | 0.00 | |
Research and Development Expense of Revenue |
95.81% | 105.64% | 96.80% | 106.06% | |
Selling, General and Administrative Expense of Revenue |
639.69% | 789.58% | 570.55% | 540.71% | |
Share Based Compensation of Revenue |
52.33% | 183.15% | 135.77% | 144.53% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 0.59 | 0.61 | 0.68 | |
Depreciation/Fixed assets |
0.20 | 0.18 | 0.15 | 2.83 | |
Capex/Depreciation |
(24.40) | (29.85) | (37.54) | (36.85) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
2.53 | 3.26 | 3.45 | 3.62 | |
Net Profit Margin |
(1,094.99%) | (1,328.81%) | (1,009.73%) | (980.05%) |
Columns are period end dates